Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

November 30, 2006

Conditions
Colorectal CancerGastric CancerGastrointestinal Carcinoid TumorGastrointestinal Stromal TumorOvarian CancerPeritoneal Cavity CancerSmall Intestine Cancer
Interventions
DRUG

carboplatin

DRUG

cisplatin

DRUG

floxuridine

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER